Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Hasılat
44,328
44,328
41,950
40,109
43,653
43,075
Hasılat Artışı (YoY)
6%
6%
5%
-8%
1%
24%
Satınalma Maliyeti
19,203
19,210
18,644
17,919
19,083
18,490
Brüt Kâr
25,125
25,118
23,306
22,190
24,570
24,585
Satış, Genel ve İdari
12,217
12,220
11,651
10,883
11,109
11,217
Araştırma ve Geliştirme
2,871
2,889
2,784
2,619
2,741
2,733
İşletme Giderleri
16,770
16,791
16,313
15,468
15,863
15,997
Diğer Finansman Gelirleri (Giderleri)
708
713
558
518
366
277
Kâr Öncesi Gelir
8,466
8,466
7,013
6,664
8,306
8,211
Kira Vergisi Gideri
1,942
1,942
-6,389
941
1,373
1,140
Net Kâr
6,524
6,524
13,402
5,723
6,933
7,071
Net Income Growth
Kâr Artışı
-51%
-51%
134%
-17%
-2%
56.99%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
1,744.51
1,748
1,748
1,749
1,764
1,789
Hisse Değişimi (Yıllık Üst Üste)
0%
0%
0%
-1%
-1%
0%
EPS (Diluted)
3.73
3.73
7.67
3.27
3.93
3.95
EPS Artışı
-51%
-51%
135%
-17%
-1%
56.99%
Öz sermaye akışı
7,395
7,395
6,351
5,059
7,804
8,648
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
56.67%
56.66%
55.55%
55.32%
56.28%
57.07%
Faaliyet Kâr Marjı
18.84%
18.78%
16.66%
16.75%
19.94%
19.93%
Kâr Marjı
14.71%
14.71%
31.94%
14.26%
15.88%
16.41%
Özsermaye Karlılık Oranı
16.68%
16.68%
15.13%
12.61%
17.87%
20.07%
EBITDA
11,471
11,443
10,211
9,965
11,974
12,126
EBITDA Marjinali
25.87%
25.81%
24.34%
24.84%
27.42%
28.15%
D&A EBITDA için
3,116
3,116
3,218
3,243
3,267
3,538
Faaliyet Kârı
8,355
8,327
6,993
6,722
8,707
8,588
Faaliyet Kâr Marjı
18.84%
18.78%
16.66%
16.75%
19.94%
19.93%
Verilen Vergi Oranı
22.93%
22.93%
-91.1%
14.12%
16.53%
13.88%
Follow-Up Questions
Abbott Laboratories'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Abbott Laboratories'in toplam varlıkları $86,713 olup, net kâr $6,524'dir.
ABT'ün temel finansal oranları nelerdir?
Abbott Laboratories'in cari oranı 2.5, net kâr marjı 14.71, hisse başına satış $25.35'dir.
Abbott Laboratories'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Abbott Laboratories en büyük gelir kaynağı Established Pharmaceutical Products olup, en son kar bildiriminde geliri 5,536,000,000 dir. Coğrafi olarak, United States , Abbott Laboratories için ana pazar olup, geliri 17,126,000,000 dir.
Abbott Laboratories kârlı mı?
evet, son mali tablolara göre Abbott Laboratories'in net kâr $6,524'dir.
Abbott Laboratories'in herhangi bir yükümlülüğü var mı?